BioScience Health Innovations, Inc.
BHICD
$4.00
-$32.04-88.90%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 260.04% | 231.53% | 208.73% | 358.81% | 611.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 260.04% | 231.53% | 208.73% | 358.81% | 611.06% |
| Cost of Revenue | 565.10% | 445.04% | 373.92% | 546.98% | 845.18% |
| Gross Profit | 190.27% | 184.88% | 170.21% | 324.94% | 572.86% |
| SG&A Expenses | 75.44% | 51.57% | 66.04% | 125.21% | 152.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 161.09% | 106.81% | 107.04% | 163.15% | 189.93% |
| Operating Income | 1,372.69% | 342.19% | 134.59% | 116.45% | 71.51% |
| Income Before Tax | 1,372.69% | 342.19% | 134.59% | 113.18% | 76.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,372.69% | 342.19% | 134.59% | 113.18% | 76.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,372.69% | 342.19% | 134.59% | 113.18% | 76.69% |
| EBIT | 1,372.69% | 342.19% | 134.59% | 116.45% | 71.51% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1,242.11% | 324.03% | 121.04% | 105.01% | 92.25% |
| Normalized Basic EPS | 1,280.43% | 325.52% | 121.58% | 105.18% | 92.51% |
| EPS Diluted | 631.88% | 264.67% | 117.27% | 92.64% | 83.69% |
| Normalized Diluted EPS | 1,244.68% | 323.45% | 121.16% | 104.94% | 92.35% |
| Average Basic Shares Outstanding | 5.14% | 4.85% | 24.38% | 60.00% | 125.67% |
| Average Diluted Shares Outstanding | 6.41% | 6.40% | 25.94% | 60.41% | 126.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |